Drug Profile
Doxycycline hyclate delayed-release - Mayne Pharma
Alternative Names: Doryx; WC 2055; WC-2031Latest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Warner Chilcott
- Developer Allergan; Mayne Pharma
- Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris; Chlamydial infections